Circulating tumor DNA (ctDNA) predicts prognosis in triple-negative breast cancer patients: A systematic review

被引：0
|
作者：
Lokanata, Edellin F. [1 ]
Frandi, Beatrix L. [1 ]
Wijaya, Jeremiah H. [1 ]
Purnomo, Alexander E. [1 ]
Tumiwa, Gabriella H. [1 ]
Lokanata, Michael G. [1 ]
Heriyanto, Rivaldo S. [1 ]
Kurniawan, Andree [2 ]
机构：
[1] Pelita Harapan Univ, Fac Med, Tangerang, Indonesia
[2] Pelita Harapan Univ, Fac Med, Dept Internal Med, Tangerang, Indonesia
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO41-2
引用
收藏
页码：S1422 / S1423
页数：2
相关论文
共 50 条
  • [1] Circulating Tumor DNA Guides Prognosis in Metastatic Triple-Negative Breast Cancer
    Zivanovic Bujak, Andjelija
    Dawson, Sarah-Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 523 - 524
  • [2] ctDNA prognosis in adjuvant triple-negative breast cancer
    Molinero, Luciana
    Renner, Derrick
    Wu, Hsin-Ta
    Qi, Nina
    Patel, Rajesh
    Chang, Ching-Wei
    Sethi, Himanshu
    Aleshin, Alexey
    Bais, Carlos
    Cameron, David
    CANCER RESEARCH, 2022, 82 (12)
  • [3] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Bagegni, Nusayba A.
    Ademuyiwa, Foluso O.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (04) : 356 - 363
  • [4] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Nusayba A. Bagegni
    Foluso O. Ademuyiwa
    Current Breast Cancer Reports, 2023, 15 : 356 - 363
  • [5] The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature
    Lisencu, Lorena Alexandra
    Tranca, Sebastian
    Bonci, Eduard-Alexandru
    Pasca, Andrei
    Mihu, Carina
    Irimie, Alexandru
    Tudoran, Oana
    Balacescu, Ovidiu
    Lisencu, Ioan Cosmin
    BIOMEDICINES, 2022, 10 (04)
  • [6] Importance of circulating tumor DNA analysis at diagnosis in early triple-negative breast cancer patients
    Park, Min-Seung
    Cho, Eun Hye
    Youn, Youngjin
    Do, In-Gu
    Woo, Hee-Yeon
    Park, Hyosoon
    Kim, Eun Young
    Kwon, Min-Jung
    BREAST CANCER, 2025, 32 (02) : 416 - 425
  • [7] Monitoring of circulating tumor DNA in metastatic triple-negative breast cancer patients undergoing chemotherapy
    Madic, Jordan
    Kiialainen, Anna
    Bidard, Francois-Clement
    Birzele, Fabian
    Ramey, Guillemette
    Vinolo, Emilie
    Leroy, Quentin
    Rio-Frio, Thomas
    Bernard, Virginia
    Lermine, Alban
    Clausen, Inga
    Giroud, Nicolas
    Schmucki, Roland
    Horn, Carsten
    Spleiss, Olivia
    Lantz, Olivier
    Stern, Marc-Henri
    Pierga, Jean-Yves
    Weisser, Martin
    Lebofsky, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions
    Saliou, Adrien
    Bidard, Francois-Clement
    Lantz, Olivier
    Stern, Marc-Henri
    Vincent-Salomon, Anne
    Proudhon, Charlotte
    Pierga, Jean-Yves
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (01) : 39 - 50
  • [9] Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
    Shang, Mao
    Chang, Chunxiao
    Pei, Yanqing
    Guan, Yin
    Chang, Jin
    Li, HuiHui
    JOURNAL OF CANCER, 2018, 9 (24): : 4627 - 4634
  • [10] Circulating tumor DNA (ctDNA) analysis for investigating resistance to chemotherapy with DNA-damage agents in patients with hereditary or sporadic triple-negative breast cancer
    Carraro, Dirce M.
    Brianese, Rafael C.
    Torrezan, Giovana T.
    de Brot, Marina
    de Paula, Claudia A. A.
    Formiga, Maria N. C.
    Sanches, Solange M.
    de Lima, Vladmir C. C.
    Makdissi, Fabiana B. A.
    CANCER RESEARCH, 2020, 80 (04)
12345